Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2
Daniel Watterson, Danushka K. Wijesundara, Naphak Modhiran, et al.
Clinical & Translational Immunology (2021) Vol. 10, Iss. 4
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein
Eduardo A. Albornoz, Alberto A. Amarilla, Naphak Modhiran, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 7, pp. 2878-2893
Open Access | Times Cited: 126
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial
Keith J. Chappell, Francesca L. Mordant, Zheyi Li, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 10, pp. 1383-1394
Open Access | Times Cited: 102
Prefusion stabilization of the Hendra and Langya virus F proteins
Patrick O. Byrne, Elizabeth G. Blade, Brian E. Fisher, et al.
Journal of Virology (2024) Vol. 98, Iss. 2
Open Access | Times Cited: 9
Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant
Bassel Akache, Tyler M. Renner, Anh Tran, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 41
Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine
Christopher L. D. McMillan, Jovin J. Y. Choo, Adi Idris, et al.
Science Advances (2021) Vol. 7, Iss. 44
Open Access | Times Cited: 40
An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission
Kairat Tabynov, Nurkeldi Turebekov, Meruert Babayeva, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 28
Structure and antigenicity of divergent Henipavirus fusion glycoproteins
Ariel Isaacs, Yu Shang Low, Kyle L. Macauslane, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Therapeutic Protein-Based Vaccines
Shaban Ahmad, Vandana Dahiya, Arpana Vibhuti, et al.
(2023), pp. 355-384
Closed Access | Times Cited: 16
The Application of Biomaterials for the Vaccine, Treatment, and Detection of SARS-CoV-2
Yuan Hu, Lili Liu, Shenghua Zhang, et al.
ACS Omega (2024) Vol. 9, Iss. 5, pp. 5175-5192
Open Access | Times Cited: 6
Vaccine process technology—A decade of progress
Barry C. Buckland, Gautam Sanyal, Todd Ranheim, et al.
Biotechnology and Bioengineering (2024) Vol. 121, Iss. 9, pp. 2604-2635
Open Access | Times Cited: 6
Skin Patch Delivery of a SARS-CoV-2 Spike DNA Vaccine Produces Broad Neutralising Antibody Responses.
Christopher L. D. McMillan, Andrea V. Corner, Danushka K. Wijesundara, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42533-e42533
Open Access
ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions
Daniel J. Rawle, Thuy T. Le, Troy Dumenil, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 7, pp. e1009723-e1009723
Open Access | Times Cited: 39
SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways
Daniel Mekonnen, Hylemariam Mihiretie Mengist, Tengchuan Jin
Expert Review of Vaccines (2021) Vol. 21, Iss. 1, pp. 69-81
Open Access | Times Cited: 38
SARS‐CoV‐2 triggers complement activation through interactions with heparan sulfate
Martin W. Lo, Alberto A. Amarilla, John D. Lee, et al.
Clinical & Translational Immunology (2022) Vol. 11, Iss. 8
Open Access | Times Cited: 18
S–6P exhibits better immunogenicity than S–2P at lower doses of COVID-19 mRNA vaccines
Zhongyi Zhu, Lei Zhang, Shuang-Bao Li, et al.
Decoding Infection and Transmission (2024) Vol. 2, pp. 100017-100017
Open Access | Times Cited: 3
Engineered dityrosine-bonding of the RSV prefusion F protein imparts stability and potency advantages
Sonal V. Gidwani, Devarshi Brahmbhatt, Aaron Zomback, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
COVID-19 Vaccine Platforms: Challenges and Safety Contemplations
Hadeel Al-Jighefee, Hoda Najjar, Muna Nizar Ahmed, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1196-1196
Open Access | Times Cited: 23
Protein engineering responses to the COVID-19 pandemic
Ching‐Lin Hsieh, Jason S. McLellan
Current Opinion in Structural Biology (2022) Vol. 74, pp. 102385-102385
Open Access | Times Cited: 18
Insect Cells for High-Yield Production of SARS-CoV-2 Spike Protein: Building a Virosome-Based COVID-19 Vaccine Candidate
Bárbara Fernandes, Rute Castro, Farien Bhoelan, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 854-854
Open Access | Times Cited: 15
Low-Dose SARS-CoV-2 S-Trimer with an Emulsion Adjuvant Induced Th1-Biased Protective Immunity
Hung‐Chun Liao, Wan-Ling Wu, Chen-Yi Chiang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4902-4902
Open Access | Times Cited: 14
Recombinant Protein Vaccines against Human Betacoronaviruses: Strategies, Approaches and Progress
Angelina Kovalenko, Ekaterina M. Ryabchevskaya, Ekaterina A. Evtushenko, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1701-1701
Open Access | Times Cited: 8
A platform technology for generating subunit vaccines against diverse viral pathogens
Andrew Young, Ariel Isaacs, Connor A. P. Scott, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variants
Naphak Modhiran, Simon Lauer, Alberto A. Amarilla, et al.
iScience (2023) Vol. 26, Iss. 7, pp. 107085-107085
Open Access | Times Cited: 7
Vaccines Against COVID-19: A Review
Carlos U. Torres-Estrella, María del Roció Reyes-Montes, Esperanza Duarte-Escalante, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 414-414
Open Access | Times Cited: 11
The role ofN-glycosylation in spike antigenicity for the SARS-CoV-2 Gamma variant
Cassandra L. Pegg, Naphak Modhiran, Rhys Parry, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top